ישראל -
עברית -
Ministry of Health
תרים 50
unipharm ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 50 mg - sildenafil
ישראל -
עברית -
Ministry of Health
ריבר טבע 15 מג
teva israel ltd - rivaroxaban - טבליות מצופות פילם - rivaroxaban 15 mg - rivaroxaban
ישראל -
עברית -
Ministry of Health
ריבר טבע 20 מג
teva israel ltd - rivaroxaban - טבליות מצופות פילם - rivaroxaban 20 mg - rivaroxaban
ישראל -
עברית -
Ministry of Health
טאדאלאמד 10 מג
inovamed pharma ltd, israel - tadalafil - טבליות מצופות פילם - tadalafil 10 mg - tadalafil
ישראל -
עברית -
Ministry of Health
טאדאלאמד 2.5 מג
inovamed pharma ltd, israel - tadalafil - טבליות מצופות פילם - tadalafil 2.5 mg - tadalafil
ישראל -
עברית -
Ministry of Health
טאדאלאמד 20 מג
inovamed pharma ltd, israel - tadalafil - טבליות מצופות פילם - tadalafil 20 mg - tadalafil
ישראל -
עברית -
Ministry of Health
טאדאלאמד 5 מג
inovamed pharma ltd, israel - tadalafil - טבליות מצופות פילם - tadalafil 5 mg - tadalafil
ישראל -
עברית -
Ministry of Health
ריברוקסבן תרו 2.5 מג
taro pharmaceutical industries ltd - rivaroxaban - טבליות מצופות פילם - rivaroxaban 2.5 mg - rivaroxaban
ישראל -
עברית -
Ministry of Health
סימבסטאטין טבע 20 מג
teva israel ltd - simvastatin - טבליה - simvastatin 20 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvastatin-teva is indicated to: - reduce the risk of total mortality by reducing coronary death - reduce the risk of non-fatal myocardial infarction - reduce the risk for undergoing myocardial revascularization procedures. - reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvastatin-teva is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvastatin-teva therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to thes
ישראל -
עברית -
Ministry of Health
סימבסטאטין טבע 10 מג
teva israel ltd - simvastatin - טבליה - simvastatin 10 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvastatin-teva is indicated to: - reduce the risk of total mortality by reducing coronary death - reduce the risk of non-fatal myocardial infarction - reduce the risk for undergoing myocardial revascularization procedures.- reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvastatin-teva is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvastatin-teva therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios.homozygous familial hypercholesterolemia: simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these